ChartRow logo
Sign in
ASND
Ascendis Pharma A/S Ordinary ShareStock · Health Care
$246.29−$9.17 (-3.59%)as of market close, Aug 13, 2026
☾ After hours:$246.23+0.00%3:59 PM ET
CompareLLYUNHJNJABBVISRGTMO

How Ascendis Pharma A/S Ordinary Share makes money

Period

How does Ascendis Pharma A/S Ordinary Share make money? This Sankey traces every dollar of revenue through the income statement — into cost of revenue, R&D, SG&A, and taxes — and shows what's left as profit. Pick any fiscal year, recent quarter, or the trailing twelve months. Straight from SEC filings.

Ascendis Pharma A/S Ordinary Share · FY2025 · year ended 2025-12-31
Revenue$815MNet loss$258M · 32%Cost of revenue$107M · 13%Gross profit$708M · 87%Operating expenses$862M · 106%R&D$344M · 42%Other opex$518M · 64%Income tax$17M · 2%Other expense$86M · 11%

Each fiscal year from SEC filings. Percentages are share of revenue, so the green profit nodes read directly as gross / operating / net margin. Line items a company doesn't break out are derived from their siblings so the flows balance; small residuals show as “Other.” For informational purposes only.